Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.89 USD
Change Today +0.17 / 2.53%
Volume 12.5K
IRIX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

iridex corp (IRIX) Snapshot

Open
$6.73
Previous Close
$6.72
Day High
$7.01
Day Low
$6.69
52 Week High
03/18/15 - $11.28
52 Week Low
10/22/14 - $6.41
Market Cap
68.9M
Average Volume 10 Days
18.2K
EPS TTM
$0.86
Shares Outstanding
10.0M
EX-Date
--
P/E TM
8.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for IRIDEX CORP (IRIX)

Related News

No related news articles were found.

iridex corp (IRIX) Related Businessweek News

No Related Businessweek News Found

iridex corp (IRIX) Details

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company offers laser consoles, such as visible (yellow) photocoagulator consoles, visible (Green) photocoagulator consoles, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations; and ophthalmic delivery devices and other products, including TxCell scanning laser delivery systems, TruFocus laser indirect ophthalmoscopes, slit lamp adapters, and operating microscope adapters. Its ophthalmic delivery devices and other products also comprise EndoProbe, a fiber optic delivery device used for endophotocoagulation; G-Probe, a sterile single-use product used in procedures to treat medically and surgically uncontrolled glaucoma; DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears; GreenTip Soft Tip Cannula used to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

106 Employees
Last Reported Date: 04/2/15
Founded in 1989

iridex corp (IRIX) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: $387.4K
Vice President of Operations
Total Annual Compensation: $247.1K
Compensation as of Fiscal Year 2014.

iridex corp (IRIX) Key Developments

IRIDEX Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Third Quarter of 2015

IRIDEX Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenues of $9,033,000 compared to $10,589,000 a year ago. Loss from operations was $747,000 compared to income from operations of $400,000 a year ago. Loss from operations benefit from provision for income taxes was $770,000 compared to income from operations before provision for income taxes of $309,000 a year ago. Net loss was $652,000 or $0.07 per basic and diluted share compared to net income of $297,000 or $0.03 per basic and diluted share a year ago. Recurring revenues were $4.8 million. For the six months, the company reported total revenues of $19,829,000 compared to $20,918,000 a year ago. Loss from operations was $344,000 compared to income from operations of $997,000 a year ago. Loss from operations benefit from provision for income taxes was $374,000 compared to income from operations before provision for income taxes of $809,000 a year ago. Net loss was $406,000 or $0.04 per diluted share compared to net income of $784,000 or $0.07 per diluted share a year ago. For the 2015 third quarter, the company anticipates revenue of $9.7 million to $10.0 million, gross margin is anticipated to come in between 47% and 49%, and operating expenses are expected to be $4.9 million to $5.1 million.

IRIDEX Corporation Announces Resignation of James H. Mackaness as Chief Financial Officer and Chief Operating Officer, Effective August 21, 2015

IRIDEX Corporation announced that James H. Mackaness, who had served as chief financial officer since 2008 and as chief operating officer since 2012, has resigned his positions with the company, effective August 21, 2015, to accept the chief financial officer position at another company. Mr. Mackaness intends to continue to serve in the CFO/COO role through the company's second quarter earnings announcement and 10-Q filing.

IRIDEX Corporation to Report Q2, 2015 Results on Aug 06, 2015

IRIDEX Corporation announced that they will report Q2, 2015 results at 5:00 PM, US Eastern Standard Time on Aug 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRIX:US $6.89 USD +0.17

IRIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bovie Medical Corp $2.30 USD -0.06
Ellex Medical Lasers Ltd A$0.38 AUD -0.005
MGC Diagnostics Corp $5.25 USD +0.22
Misonix Inc $11.37 USD +0.39
Utah Medical Products Inc $52.89 USD +2.26
View Industry Companies
 

Industry Analysis

IRIX

Industry Average

Valuation IRIX Industry Range
Price/Earnings 7.9x
Price/Sales 1.7x
Price/Book 2.1x
Price/Cash Flow 7.8x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIDEX CORP, please visit www.iridex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.